Revcovi

Buyer: Southern Health and Social Care Trust

Deadline

Not available — this notice may describe a possible future opportunity.

Region

Not specified

Value

£3,996,000

Type

Award,contract

SME fit

—

Duration

—

Description

Procurement of Revcovi, an approved enzyme replacement therapy (ERT) indicated for the treatment of adenosine deaminase severe combined immune deficiency.

Awarded to

Chiesi Limited £3,996,000

Quick actions

View original notice

Key details

CPV category: —
Procurement method: Direct award
Published: 03 Sep 2025 09:29
VCSE suitable: —

Reference

OCID: ocds-h6vhtk-0592c8
Notice ID: ocds-h6vhtk-0592c8
In our database since: 18 Aug 2026